Better ways to create imaging and treatment tools for bone infections
Catch and Release Radiolabeled Peptides: a new technology for radiotracer development
This project aims to create a new, easier way to make special molecules called radiolabeled peptides, which could help find and treat bone infections more effectively.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University New York Stony Brook NIH-funded |
| Lab location | 1 site (Stony Brook, United States) |
| Project ID | NIH-11127539 on NIH RePORTER |
What this research studies
Researchers are developing a new method to create special molecules called radiolabeled peptides, which are useful for both imaging and treating diseases like bone infections. This new approach builds on existing chemistry to make these peptides with high purity and activity, without needing complex purification steps. The goal is to make the process faster and more automated, which would speed up how quickly these promising tools can be used in patient care. This technology could also open doors for using these molecules in discovering new drugs.
Who could benefit from this research
Good fit: Patients who could eventually benefit from this research are those living with bone infections, as this technology aims to improve their diagnosis and treatment.
Not a fit: Patients without bone infections would not directly benefit from this specific technology, as its focus is on improving tools for that condition.
Why it matters
Potential benefit: If successful, this technology could lead to more effective and accessible imaging and treatment options for patients with bone infections.
How similar studies have performed: This project introduces a novel approach to radiolabeling peptides, building on existing chemistry but offering a new, potentially more efficient method.
Where this research is happening
Stony Brook, United States
- State University New York Stony Brook — Stony Brook, United States (Active)
Researchers
- Principal investigator: Parker, Matthew — State University New York Stony Brook
- Study coordinator: Parker, Matthew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.